Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Horton

Showing results (271-280 of 322) with videos related to

Pageof 33
Sort By:
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 20, 2024
New Diagnoses of Juvenile Idiopathic Arthritis Early in the COVID-19 Pandemic: Analysis of a Large United States Commercial Insurance DatabaseSanika Rege, Lauren E Parlett, Amanda Neikirk, et al.
Ophthalmology|June 18, 2011
Special requirements for electronic health record systems in ophthalmologyMichael F Chiang, Michael V Boland, Allen Brewer, et al.
Neurochemical Research|August 1, 2015
r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine ReinforcementJoshua S Beckmann, Andrew C Meyer, M Pivavarchyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 24, 2010
meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine releaseDavid B Horton, Kiran B Siripurapu, Seth D Norrholm, et al.
Psychiatric Services (Washington, D.C.)|February 8, 2023
Geographic Trends in Pediatric Psychotropic Medication Dispensing Before and After the Start of the COVID-19 PandemicGreta Bushnell, Jenny W Sun, Susan dosReis, et al.
BMC Infectious Diseases|November 17, 2020
Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers in New Jersey, at the onset of the U.S. COVID-19 pandemicEmily S Barrett, Daniel B Horton, Jason Roy, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers at the onset of the U.S. COVID-19 epidemicEmily S Barrett, Daniel B Horton, Jason Roy, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 11, 2020
Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) studyRishi J Desai, Vijay R Varma, Tobias Gerhard, et al.
Brain Communications|November 4, 2022
No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines studyRishi J Desai, Mufaddal Mahesri, Su Been Lee, et al.
Pharmacoepidemiology and Drug Safety|September 10, 2023
Overview of global real-world data sources for pediatric pharmacoepidemiologic researchGerold T Wharton, Claudia Becker, Dimitri Bennett, et al.
Pageof 33

Showing results (271-280 of 322) with videos related to

Sort By:
Pageof 33
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 20, 2024
New Diagnoses of Juvenile Idiopathic Arthritis Early in the COVID-19 Pandemic: Analysis of a Large United States Commercial Insurance DatabaseSanika Rege, Lauren E Parlett, Amanda Neikirk, et al.
Ophthalmology|June 18, 2011
Special requirements for electronic health record systems in ophthalmologyMichael F Chiang, Michael V Boland, Allen Brewer, et al.
Neurochemical Research|August 1, 2015
r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine ReinforcementJoshua S Beckmann, Andrew C Meyer, M Pivavarchyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 24, 2010
meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine releaseDavid B Horton, Kiran B Siripurapu, Seth D Norrholm, et al.
Psychiatric Services (Washington, D.C.)|February 8, 2023
Geographic Trends in Pediatric Psychotropic Medication Dispensing Before and After the Start of the COVID-19 PandemicGreta Bushnell, Jenny W Sun, Susan dosReis, et al.
BMC Infectious Diseases|November 17, 2020
Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers in New Jersey, at the onset of the U.S. COVID-19 pandemicEmily S Barrett, Daniel B Horton, Jason Roy, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers at the onset of the U.S. COVID-19 epidemicEmily S Barrett, Daniel B Horton, Jason Roy, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 11, 2020
Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) studyRishi J Desai, Vijay R Varma, Tobias Gerhard, et al.
Brain Communications|November 4, 2022
No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines studyRishi J Desai, Mufaddal Mahesri, Su Been Lee, et al.
Pharmacoepidemiology and Drug Safety|September 10, 2023
Overview of global real-world data sources for pediatric pharmacoepidemiologic researchGerold T Wharton, Claudia Becker, Dimitri Bennett, et al.
Pageof 33